RSK signaling in myeloid malignancies: biology, disease dependency, and therapeutic targeting
{{output}}
Acute myeloid leukemia (AML) and related myeloid malignancies remain clinically challenging despite recent advances in molecular profiling and targeted therapy. Although recurrent oncogenic drivers have improved disease classification and informed therapeutic ... ...
